Kerstin Schultz

Kerstin Schultz has a diverse and extensive work experience spanning various roles in the pharmaceutical and healthcare industry. Kerstin currently serves as the Vice President, Global Team Leader at Centessa Pharmaceuticals, where they are leading the development of a novel bispecific for solid tumors. Prior to that, they worked at Astellas Pharma as the Vice President, Head of Global Development Project Leaders, overseeing the successful development and approval of a first-in-class product. Kerstin also held key leadership roles at Jazz Pharmaceuticals, Brainscope Company Inc., Allergan, Baxter International Inc., and Kearney, where they demonstrated their expertise in project management, strategy, and business development. Overall, Kerstin Schultz has a track record of successful achievements and contributions to the companies they have worked with.

Kerstin Schultz holds an MBA in International Business and Finance from Northwestern University - Kellogg School of Management. Additionally, they have a Master of Science degree in Law from the School of Business, Economics and Law at the University of Gothenburg.